|
valemetostat tosylate Clinical Trials
3 actively recruiting trials across 3 locations
Also known as: DS-3201b, valemetostat
Pipeline
Phase 1: 1Phase 2: 1Phase 1/2: 1
Top Sponsors
- Daiichi Sankyo2
- Alliance for Clinical Trials in Oncology1
Indications
- Cancer3
- Castration-Resistant Prostate Carcinoma1
- Stage IVB Prostate Cancer AJCC v81
- Advanced Solid Tumor1
- Lung Cancer1
Tucson, Arizona1 trial
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Banner University Medical Center - Tucson
Phase 2
Irvine, California1 trial
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid Tumors
City of Hope At Orange County Lennar Foundation Cancer Center
Phase 1
La Jolla, California1 trial
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
University of California San Diego (Ucsd)-Moores Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.